Regeneron vs Ankr

Side-by-side comparison of AI visibility scores, market position, and capabilities

Regeneron leads in AI visibility (75 vs 33)
Regeneron logo

Regeneron

LeaderLife Sciences & BioTech

Biopharmaceuticals

Tarrytown NY biopharma giant; creator of Dupixent (>$14B revenue), Eylea, and Kevzara. Velocity Genome platform drives fast antibody and bispecific drug discovery.

AI VisibilityBeta
Overall Score
B75
Category Rank
#2 of 2
AI Consensus
73%
Trend
up
Per Platform
ChatGPT
72
Perplexity
76
Gemini
84

About

Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized mouse technology that dramatically accelerates the discovery of human antibodies—and has used it to produce multiple best-in-class biologics across inflammatory, oncologic, and eye diseases.\n\nRegeneron's commercial portfolio is anchored by Dupixent (dupilumab), developed with Sanofi, which has become one of the best-selling drugs globally with over $14 billion in 2024 revenues, treating atopic dermatitis, asthma, COPD, and other type-2 inflammatory conditions. Additional key products include Eylea (aflibercept) for macular degeneration and PRALUENT for cardiovascular cholesterol lowering. The company's bispecific antibody pipeline, cancer vaccines in collaboration with BioNTech, and gene therapy programs represent its next growth wave.\n\nRegeneron reported over $14 billion in annual revenue in 2024 and maintains a world-class science culture, consistently ranking among the top companies for R&D productivity and employee satisfaction. Its Tarrytown campus houses more than 10,000 employees and remains a leading independent US biopharmaceutical innovator.

Full profile
Ankr logo

Ankr

EmergingWeb3

Multi-Chain RPC Infrastructure

Decentralized Web3 infrastructure with RPC node access across 30+ blockchains; globally distributed nodes reduce latency; premium dedicated nodes for apps needing guaranteed throughput.

AI VisibilityBeta
Overall Score
D33
Category Rank
#1 of 1
AI Consensus
56%
Trend
up
Per Platform
ChatGPT
40
Perplexity
40
Gemini
29

About

Ankr is a Web3 infrastructure platform offering remote procedure call node access to more than 30 blockchain networks through a globally distributed network of nodes run by independent operators. Unlike centralized providers that operate their own data centers exclusively, Ankr's decentralized architecture routes requests across geographically distributed nodes, improving latency for users in regions underserved by US- or EU-centric infrastructure. Its public free-tier RPC endpoints — available for Ethereum, BNB Chain, Polygon, Avalanche, Fantom, and dozens of others — have made Ankr one of the most widely used infrastructure providers in the multi-chain developer ecosystem.

Full profile

AI Visibility Head-to-Head

75
Overall Score
33
#2
Category Rank
#1
73
AI Consensus
56
up
Trend
up
72
ChatGPT
40
76
Perplexity
40
84
Gemini
29
77
Claude
25
79
Grok
40

Key Details

Category
Biopharmaceuticals
Multi-Chain RPC Infrastructure
Tier
Leader
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Regeneron
Biopharmaceuticals
Only Ankr
Multi-Chain RPC Infrastructure

Integrations

Only Regeneron

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.